Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Benefits of aldosterone receptor antagonism in chronic kidney disease: the BARACK-D RCT

Hobbs FDR. et al, (2025), Health Technology Assessment, 29

D-Mannose for Prevention of Recurrent Urinary Tract Infection Among Women: A Randomized Clinical Trial

Hayward G. et al, (2024), JAMA Internal Medicine, 184, 619 - 628

Digitally augmented, parent-led CBT versus treatment as usual for child anxiety problems in child mental health services in England and Northern Ireland: a pragmatic, non-inferiority, clinical effectiveness and cost-effectiveness randomised controlled trial

Creswell C. et al, (2024), The Lancet Psychiatry, 11, 193 - 209

Cost-utility analysis of molnupiravir plus usual care versus usual care alone as early treatment for community-based adults with COVID-19 and increased risk of adverse outcomes in the UK PANORAMIC trial.

Png ME. et al, (2024), Br J Gen Pract

Low-dose spironolactone and cardiovascular outcomes in moderate stage chronic kidney disease: a randomized controlled trial

Hobbs FDR. et al, (2024), Nature Medicine

Clinical and cost-effectiveness of nurse-delivered sleep restriction therapy for insomnia in primary care (HABIT): a pragmatic, superiority, open-label, randomised controlled trial

Kyle SD. et al, (2023), The Lancet, 402, 975 - 987

Evidence-based appraisal of two guidelines for the diagnosis of suspected, uncomplicated urinary tract infections in primary care: a diagnostic accuracy validation study

Fanshawe TR. et al, (2023), Journal of Antimicrobial Chemotherapy, 78, 2080 - 2088

Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial

Butler CC. et al, (2023), The Lancet, 401, 281 - 293

Effect of Self-monitoring of Blood Pressure on Diagnosis of Hypertension during Higher-Risk Pregnancy: The BUMP 1 Randomized Clinical Trial

Tucker KL. et al, (2022), JAMA, 327, 1656 - 1665

Urine collection devices to reduce contamination in urine samples for diagnosis of uncomplicated UTI: A single-blind randomised controlled trial in primary care

Hayward G. et al, (2022), British Journal of General Practice, 72, 1 - 9

Blood pressure self-monitoring in pregnant women from ethnic minorities and deprived areas: A secondary analysis of the BUMP 1 trial

Omorodion BE. et al, (2022), JOURNAL OF HUMAN HYPERTENSION, 36, 3 - 4

Hospital at Home admission avoidance with comprehensive geriatric assessment to maintain living at home for people aged 65 years and over: a RCT

Shepperd S. et al, (2022), Health and Social Care Delivery Research, 10

Is Comprehensive Geriatric Assessment Admission Avoidance Hospital at Home an Alternative to Hospital Admission for Older Persons? : A Randomized Trial.

Shepperd S. et al, (2021), Ann Intern Med

Efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (TASMINH4): an unmasked randomised controlled trial

McManus RJ. et al, (2018), The Lancet, 391, 949 - 959

Self-management of postnatal hypertension the SNAP-HT trial

Cairns AE. et al, (2018), Hypertension, 72, 425 - 432